Recent patents on therapeutic activities of xanthohumol: a prenylated chalconoid from hops
There is expanding proof that specific natural compounds found in plants have additional conventional medicinal properties. One such compound is xanthohumol (XN), which is being explored as an antimicrobial, anticarcinogenic, antidiabetic and anti-inflammatory agent – aside from its utilization in d...
Saved in:
Published in | Pharmaceutical patent analyst Vol. 10; no. 1; pp. 37 - 49 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Newlands Press Ltd
01.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There is expanding proof that specific natural compounds found in plants have additional conventional medicinal properties. One such compound is xanthohumol (XN), which is being explored as an antimicrobial, anticarcinogenic, antidiabetic and anti-inflammatory agent – aside from its utilization in dealing with conditions like autism, bone and skin improvement and microbial infections, lipid-related illnesses, and so on. XN is reported to suppress the uncontrolled production of inflammatory mediators responsible for diseases including cardiovascular disease, neurodegeneration and tumors. Further, it is accounted to limit adipogenesis and control obesity by focusing on principal adipocyte marker proteins. It is most generally utilized in the brewing industry as an additive and flavoring agent to add bitterness and aroma to beer. Present investigation sum up the patents filed in most recent 2 years on development of different pharmaceutical mixes and strategies dependent on various therapeutic potentials of XN. |
---|---|
AbstractList | There is expanding proof that specific natural compounds found in plants have additional conventional medicinal properties. One such compound is xanthohumol (XN), which is being explored as an antimicrobial, anticarcinogenic, antidiabetic and anti-inflammatory agent - aside from its utilization in dealing with conditions like autism, bone and skin improvement and microbial infections, lipid-related illnesses, and so on. XN is reported to suppress the uncontrolled production of inflammatory mediators responsible for diseases including cardiovascular disease, neurodegeneration and tumors. Further, it is accounted to limit adipogenesis and control obesity by focusing on principal adipocyte marker proteins. It is most generally utilized in the brewing industry as an additive and flavoring agent to add bitterness and aroma to beer. Present investigation sum up the patents filed in most recent 2 years on development of different pharmaceutical mixes and strategies dependent on various therapeutic potentials of XN. |
Author | Tuli, Hardeep S Aggarwal, Diwakar Upadhyay, Sushil K Singh, Raj |
AuthorAffiliation | 1Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India |
AuthorAffiliation_xml | – name: 1Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India |
Author_xml | – sequence: 1 givenname: Diwakar orcidid: 0000-0001-6920-4341 surname: Aggarwal fullname: Aggarwal, Diwakar organization: Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India – sequence: 2 givenname: Sushil K orcidid: 0000-0002-1229-4275 surname: Upadhyay fullname: Upadhyay, Sushil K organization: Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India – sequence: 3 givenname: Raj orcidid: 0000-0002-6331-9196 surname: Singh fullname: Singh, Raj organization: Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India – sequence: 4 givenname: Hardeep S orcidid: 0000-0003-1155-0094 surname: Tuli fullname: Tuli, Hardeep S organization: Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33445965$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kDtv1jAUhi1URC90ZEUeWVJ8j81WVYVWqoSEOrFYjnOiGCV2sB1E_z3-9LXdmM57dJ7zDs85OokpAkIfKLkSVMrP2-Y6RhjpCGHqDTpjRKhOG8VOXrMUp-iylF-EEEpZr41-h045F0IaJc_Qzx_gIVa8udpGwSniOkN2G-w1eOx8DX9CDdAuE_7rYp3TvK9p-YId3jLEp6U9jtjPbvEppjDiKacVz2kr79HbyS0FLp_nBXr8evt4c9c9fP92f3P90HnW89o5YwbVj7QfyaCkFFJpweggKQcycd4S80xzJ_kwKEcN85xoL7QYlaEj5xfo07F2y-n3DqXaNRQPy-IipL1YJnottaFUNbQ7oj6nUjJMdsthdfnJUmIPQm0Tag9C7UFo4z8-V-_DCuMr_aKvAeYITHvdMxQfIHqwx619BB8i_Kf8H66shjs |
CitedBy_id | crossref_primary_10_13005_bpj_2357 crossref_primary_10_1002_mnfr_202100831 crossref_primary_10_1007_s40495_021_00265_6 crossref_primary_10_1080_03610470_2024_2350108 |
Cites_doi | 10.1055/s-0038-1623534 10.1006/bbrc.1994.1614 10.3389/fphar.2018.00530 10.1111/j.1365-2672.1992.tb01843.x 10.1016/j.phymed.2006.05.010 10.1002/mnfr.200500091 10.1002/mnfr.201800923 10.1021/jf034263z 10.1016/j.neuint.2010.11.008 10.1016/j.foodchem.2009.02.008 10.3109/00498259609046726 10.1016/j.bbagen.2019.08.001 10.3389/fphys.2015.00140 10.1039/b100917f 10.1016/j.phytochem.2004.04.025 10.1002/mnfr.201100554 10.1002/chem.200902058 10.1002/mnfr.201400245 10.1007/BF01970171 10.1021/acs.jafc.6b03933 10.1055/s-0037-1613907 10.1016/j.ejca.2005.04.012 10.1124/dmd.105.008250 10.1016/j.bbagen.2012.12.005 10.1021/jf901244k 10.1080/13813455.2016.1247284 10.1016/j.lfs.2017.12.005 10.1053/j.gastro.2013.10.013 10.1002/mnfr.201500613 10.1371/journal.pone.0049415 10.3390/ijms20051203 10.4196/kjpp.2012.16.3.187 10.4103/0975-7406.62694 10.3390/nu11040879 10.1016/B978-0-12-373891-2.00045-6 10.3390/molecules23082059 10.1016/B978-0-12-373891-2.00054-7 10.1016/j.phytochem.2012.04.018 10.1016/j.lfs.2016.01.017 10.1602/neurorx.2.4.572 10.1159/000227448 10.1074/jbc.M403456200 10.1177/1934578X0900400501 10.2174/1872213X13666190816160240 10.1049/joe.2019.0629 10.1093/jac/dki099 10.1016/S0167-6296(02)00126-1 10.1079/BJN20041384 10.1093/jn/136.7.1862 10.1021/jf0002995 10.1080/004982500237631 10.7150/ijbs.37481 10.1016/j.jep.2008.01.011 10.1039/b909988n 10.1021/jf0014157 10.1111/cas.13441 10.1016/j.yexmp.2012.05.003 10.1093/jn/138.7.1310 10.1016/B978-0-12-373891-2.00022-5 10.4155/ppa-2017-0035 10.1016/j.critrevonc.2018.05.019 10.1002/ardp.19833160208 10.1007/s00204-013-1028-2 10.1021/jf061647r 10.1055/s-2004-827180 10.3390/ijms20030656 10.3390/molecules20010754 10.1016/j.ejmech.2017.07.024 10.1016/j.phymed.2004.07.006 10.3390/molecules24081617 10.2174/1872213X13666190621125048 10.1016/j.bbamem.2013.09.009 10.1016/j.phymed.2008.12.021 10.1021/acs.jafc.7b06010 10.3109/10715762.2010.515216 10.3389/fvets.2017.00131 10.1021/np049783i 10.3390/molecules23030660 10.1016/B978-0-12-373891-2.00052-3 10.3390/biom9110738 10.1021/tx020100d 10.1016/j.phymed.2007.09.008 10.1007/978-3-030-11211-0_1 10.1016/j.lfs.2015.06.004 10.1007/s40291-018-0329-9 10.1556/APhysiol.99.2012.2.6 10.3389/fphar.2019.01336 10.1016/j.phymed.2010.01.007 |
ContentType | Journal Article |
Copyright | 2021 Newlands Press |
Copyright_xml | – notice: 2021 Newlands Press |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.4155/ppa-2020-0026 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2046-8962 |
EndPage | 49 |
ExternalDocumentID | 10_4155_ppa_2020_0026 33445965 |
Genre | Journal Article |
GroupedDBID | 1LI ACGFS ADBBV ALMA_UNASSIGNED_HOLDINGS EBS 0R~ 4.4 7X7 8FI 8FJ ABJNI ABUWG ACWKX AFFYO AFKRA ALIPV BENPR BPHCQ BVXVI CCPQU EJD FYUFA H13 HMCUK NPM PQQKQ PROAC RPM TDBHL TFL TMEDX TVSSL UKHRP AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c273t-a99b67d17d0b6554568421b513e0f331b52c283a53bb6a192c308c484d691d33 |
ISSN | 2046-8954 |
IngestDate | Fri Aug 16 04:28:18 EDT 2024 Thu Sep 12 18:04:48 EDT 2024 Sat Sep 28 08:33:32 EDT 2024 Wed Jan 20 05:30:17 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | bone disorders anti-inflammatory pharmaceutical antidiabetic flavonoids |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c273t-a99b67d17d0b6554568421b513e0f331b52c283a53bb6a192c308c484d691d33 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0000-0001-6920-4341 0000-0003-1155-0094 0000-0002-1229-4275 0000-0002-6331-9196 |
PMID | 33445965 |
PQID | 2478589116 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_2478589116 crossref_primary_10_4155_ppa_2020_0026 pubmed_primary_33445965 futurescience_futuremedicine_10_4155_ppa_2020_0026 |
ProviderPackageCode | 1LI |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Pharmaceutical patent analyst |
PublicationTitleAlternate | Pharm Pat Anal |
PublicationYear | 2021 |
Publisher | Newlands Press Ltd |
Publisher_xml | – name: Newlands Press Ltd |
References | e_1_3_3_50_1 e_1_3_3_77_1 Hänsel R (e_1_3_3_42_1) 1982; 45 e_1_3_3_117_1 e_1_3_3_39_1 Hänsel R (e_1_3_3_40_1) 1980; 35 e_1_3_3_132_1 e_1_3_3_16_1 e_1_3_3_35_1 e_1_3_3_58_1 e_1_3_3_136_1 e_1_3_3_12_1 e_1_3_3_31_1 e_1_3_3_54_1 e_1_3_3_73_1 e_1_3_3_96_1 e_1_3_3_113_1 e_1_3_3_88_1 e_1_3_3_9_1 Miranda CL (e_1_3_3_38_1) 2000; 28 e_1_3_3_105_1 e_1_3_3_128_1 e_1_3_3_109_1 e_1_3_3_27_1 e_1_3_3_46_1 e_1_3_3_69_1 e_1_3_3_80_1 e_1_3_3_120_1 e_1_3_3_5_1 e_1_3_3_23_1 e_1_3_3_65_1 e_1_3_3_84_1 e_1_3_3_101_1 e_1_3_3_124_1 e_1_3_3_30_1 e_1_3_3_76_1 e_1_3_3_99_1 Hieronymus S (e_1_3_3_7_1) 2012 e_1_3_3_116_1 e_1_3_3_139_1 e_1_3_3_19_1 e_1_3_3_91_1 e_1_3_3_131_1 e_1_3_3_57_1 e_1_3_3_34_1 e_1_3_3_72_1 e_1_3_3_95_1 e_1_3_3_112_1 e_1_3_3_135_1 e_1_3_3_11_1 e_1_3_3_53_1 e_1_3_3_41_1 e_1_3_3_87_1 e_1_3_3_60_1 Deeb D (e_1_3_3_15_1) 2010; 30 e_1_3_3_108_1 e_1_3_3_8_1 e_1_3_3_127_1 Biendl M (e_1_3_3_49_1) 2008 e_1_3_3_100_1 e_1_3_3_26_1 e_1_3_3_68_1 e_1_3_3_45_1 e_1_3_3_83_1 e_1_3_3_104_1 e_1_3_3_4_1 e_1_3_3_22_1 e_1_3_3_64_1 e_1_3_3_123_1 e_1_3_3_52_1 e_1_3_3_75_1 e_1_3_3_98_1 e_1_3_3_71_1 e_1_3_3_79_1 e_1_3_3_119_1 e_1_3_3_138_1 e_1_3_3_18_1 Lee YM (e_1_3_3_25_1) 2012; 2 e_1_3_3_14_1 e_1_3_3_37_1 e_1_3_3_90_1 e_1_3_3_111_1 e_1_3_3_130_1 e_1_3_3_10_1 e_1_3_3_33_1 e_1_3_3_56_1 e_1_3_3_94_1 e_1_3_3_115_1 e_1_3_3_134_1 e_1_3_3_86_1 Dimpfel W (e_1_3_3_66_1) 2004; 9 Vonderheid-Guth B (e_1_3_3_61_1) 2000; 5 e_1_3_3_107_1 e_1_3_3_29_1 e_1_3_3_48_1 e_1_3_3_122_1 e_1_3_3_141_1 e_1_3_3_3_1 e_1_3_3_44_1 e_1_3_3_67_1 e_1_3_3_82_1 e_1_3_3_103_1 e_1_3_3_126_1 e_1_3_3_97_1 e_1_3_3_51_1 e_1_3_3_78_1 e_1_3_3_70_1 e_1_3_3_140_1 Lecce G (e_1_3_3_63_1) 2001; 86 e_1_3_3_118_1 e_1_3_3_17_1 De Keukeleire J (e_1_3_3_43_1) 2003; 16 e_1_3_3_110_1 e_1_3_3_133_1 e_1_3_3_13_1 e_1_3_3_59_1 e_1_3_3_36_1 e_1_3_3_93_1 e_1_3_3_114_1 e_1_3_3_137_1 e_1_3_3_55_1 e_1_3_3_32_1 e_1_3_3_74_1 e_1_3_3_62_1 e_1_3_3_89_1 e_1_3_3_6_1 e_1_3_3_129_1 e_1_3_3_106_1 e_1_3_3_28_1 Grubb PW (e_1_3_3_92_1) 1999 Aronson JK (e_1_3_3_21_1) 2015 e_1_3_3_24_1 e_1_3_3_121_1 e_1_3_3_47_1 e_1_3_3_81_1 e_1_3_3_20_1 e_1_3_3_125_1 e_1_3_3_85_1 e_1_3_3_102_1 |
References_xml | – ident: e_1_3_3_18_1 doi: 10.1055/s-0038-1623534 – ident: e_1_3_3_134_1 – ident: e_1_3_3_120_1 – volume: 86 start-page: 1379 year: 2001 ident: e_1_3_3_63_1 article-title: Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells publication-title: J. Clin. Endocrinol. Metab. contributor: fullname: Lecce G – ident: e_1_3_3_103_1 – ident: e_1_3_3_35_1 doi: 10.1006/bbrc.1994.1614 – ident: e_1_3_3_117_1 – ident: e_1_3_3_104_1 – ident: e_1_3_3_17_1 doi: 10.3389/fphar.2018.00530 – ident: e_1_3_3_29_1 doi: 10.1111/j.1365-2672.1992.tb01843.x – ident: e_1_3_3_65_1 doi: 10.1016/j.phymed.2006.05.010 – ident: e_1_3_3_95_1 doi: 10.1002/mnfr.200500091 – ident: e_1_3_3_59_1 doi: 10.1002/mnfr.201800923 – ident: e_1_3_3_118_1 – volume: 16 start-page: 4436 year: 2003 ident: e_1_3_3_43_1 article-title: Formation and accumulation of α-acids, β-acids, desmethylxanthohumol, and xanthohumol during flowering of hops (Humulus lupulus L.) publication-title: J. Agri. Food Chem. doi: 10.1021/jf034263z contributor: fullname: De Keukeleire J – ident: e_1_3_3_89_1 doi: 10.1016/j.neuint.2010.11.008 – ident: e_1_3_3_116_1 – ident: e_1_3_3_102_1 – ident: e_1_3_3_3_1 doi: 10.1016/j.foodchem.2009.02.008 – ident: e_1_3_3_119_1 – ident: e_1_3_3_36_1 doi: 10.3109/00498259609046726 – ident: e_1_3_3_85_1 doi: 10.1016/j.bbagen.2019.08.001 – ident: e_1_3_3_81_1 doi: 10.3389/fphys.2015.00140 – ident: e_1_3_3_10_1 doi: 10.1039/b100917f – ident: e_1_3_3_23_1 doi: 10.1016/j.phytochem.2004.04.025 – ident: e_1_3_3_68_1 doi: 10.1002/mnfr.201100554 – ident: e_1_3_3_132_1 – ident: e_1_3_3_5_1 doi: 10.1002/chem.200902058 – ident: e_1_3_3_53_1 doi: 10.1002/mnfr.201400245 – volume: 9 start-page: 423 issue: 9 year: 2004 ident: e_1_3_3_66_1 article-title: Effects of lozenge containing lavender oil, extracts from hops, lemon balm and oat on electrical brain activity of volunteers publication-title: Eur. J. Med. Res. contributor: fullname: Dimpfel W – ident: e_1_3_3_28_1 doi: 10.1007/BF01970171 – ident: e_1_3_3_105_1 – ident: e_1_3_3_9_1 doi: 10.1021/acs.jafc.6b03933 – ident: e_1_3_3_121_1 – volume: 35 start-page: 1096 issue: 11 year: 1980 ident: e_1_3_3_40_1 article-title: Sedative-hypnotic compounds in the exhalation of hops, II publication-title: Z. Naturforsch. contributor: fullname: Hänsel R – volume-title: Fundamentals of Global Law, Practice and Strategy (2nd Edition). year: 1999 ident: e_1_3_3_92_1 contributor: fullname: Grubb PW – ident: e_1_3_3_30_1 doi: 10.1055/s-0037-1613907 – ident: e_1_3_3_100_1 doi: 10.1016/j.ejca.2005.04.012 – ident: e_1_3_3_123_1 – ident: e_1_3_3_37_1 doi: 10.1124/dmd.105.008250 – ident: e_1_3_3_114_1 – ident: e_1_3_3_86_1 doi: 10.1016/j.bbagen.2012.12.005 – ident: e_1_3_3_24_1 doi: 10.1021/jf901244k – ident: e_1_3_3_82_1 doi: 10.1080/13813455.2016.1247284 – ident: e_1_3_3_101_1 – ident: e_1_3_3_72_1 doi: 10.1016/j.lfs.2017.12.005 – ident: e_1_3_3_16_1 doi: 10.1053/j.gastro.2013.10.013 – ident: e_1_3_3_46_1 doi: 10.1002/mnfr.201500613 – ident: e_1_3_3_33_1 doi: 10.1371/journal.pone.0049415 – ident: e_1_3_3_55_1 doi: 10.3390/ijms20051203 – ident: e_1_3_3_129_1 – ident: e_1_3_3_41_1 doi: 10.4196/kjpp.2012.16.3.187 – ident: e_1_3_3_90_1 doi: 10.4103/0975-7406.62694 – ident: e_1_3_3_99_1 doi: 10.3390/nu11040879 – ident: e_1_3_3_14_1 doi: 10.1016/B978-0-12-373891-2.00045-6 – ident: e_1_3_3_22_1 doi: 10.3390/molecules23082059 – ident: e_1_3_3_130_1 – ident: e_1_3_3_20_1 doi: 10.1016/B978-0-12-373891-2.00054-7 – ident: e_1_3_3_133_1 – ident: e_1_3_3_96_1 doi: 10.1016/j.phytochem.2012.04.018 – ident: e_1_3_3_79_1 doi: 10.1016/j.lfs.2016.01.017 – ident: e_1_3_3_93_1 doi: 10.1602/neurorx.2.4.572 – ident: e_1_3_3_26_1 doi: 10.1159/000227448 – ident: e_1_3_3_136_1 – ident: e_1_3_3_139_1 – ident: e_1_3_3_50_1 doi: 10.1074/jbc.M403456200 – ident: e_1_3_3_47_1 doi: 10.1177/1934578X0900400501 – ident: e_1_3_3_75_1 doi: 10.2174/1872213X13666190816160240 – ident: e_1_3_3_124_1 doi: 10.1049/joe.2019.0629 – ident: e_1_3_3_12_1 doi: 10.1093/jac/dki099 – ident: e_1_3_3_80_1 doi: 10.1016/j.neuint.2010.11.008 – ident: e_1_3_3_91_1 doi: 10.1016/S0167-6296(02)00126-1 – ident: e_1_3_3_112_1 – ident: e_1_3_3_39_1 doi: 10.1079/BJN20041384 – ident: e_1_3_3_109_1 – ident: e_1_3_3_56_1 doi: 10.1093/jn/136.7.1862 – ident: e_1_3_3_94_1 doi: 10.1021/jf0002995 – volume: 28 start-page: 1297 issue: 11 year: 2000 ident: e_1_3_3_38_1 article-title: Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline, mediated by cDNA-expressed human CYP1A2 publication-title: Drug Metab. Dispos. contributor: fullname: Miranda CL – ident: e_1_3_3_34_1 doi: 10.1080/004982500237631 – ident: e_1_3_3_111_1 – ident: e_1_3_3_83_1 doi: 10.7150/ijbs.37481 – ident: e_1_3_3_126_1 – ident: e_1_3_3_19_1 doi: 10.1016/j.jep.2008.01.011 – ident: e_1_3_3_11_1 doi: 10.1039/b909988n – ident: e_1_3_3_54_1 doi: 10.1021/jf0014157 – ident: e_1_3_3_87_1 doi: 10.1111/cas.13441 – ident: e_1_3_3_97_1 doi: 10.1016/j.yexmp.2012.05.003 – ident: e_1_3_3_110_1 – ident: e_1_3_3_127_1 – ident: e_1_3_3_57_1 doi: 10.1093/jn/138.7.1310 – ident: e_1_3_3_138_1 – ident: e_1_3_3_6_1 doi: 10.1016/B978-0-12-373891-2.00022-5 – volume: 45 start-page: 224 year: 1982 ident: e_1_3_3_42_1 article-title: The sedative-hypnotic principle of hops. 3. Communication: contents of 2-methyl-3-butene-2-ol in hops and hop preparations publication-title: Planta Med. contributor: fullname: Hänsel R – ident: e_1_3_3_77_1 doi: 10.4155/ppa-2017-0035 – ident: e_1_3_3_74_1 doi: 10.1016/j.critrevonc.2018.05.019 – volume: 30 start-page: 3333 year: 2010 ident: e_1_3_3_15_1 article-title: Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells publication-title: Anticancer Res. contributor: fullname: Deeb D – ident: e_1_3_3_140_1 – ident: e_1_3_3_108_1 – ident: e_1_3_3_67_1 doi: 10.1002/ardp.19833160208 – ident: e_1_3_3_88_1 doi: 10.1007/s00204-013-1028-2 – volume: 2 start-page: 10 year: 2012 ident: e_1_3_3_25_1 article-title: Xanthohumol, a prenylated flavonoid from hops (Humulus lupulus), prevents platelet activation in human platelets publication-title: Evid. Based Complement. Alternat. Med. contributor: fullname: Lee YM – ident: e_1_3_3_44_1 doi: 10.1021/jf061647r – ident: e_1_3_3_64_1 doi: 10.1055/s-2004-827180 – ident: e_1_3_3_113_1 – ident: e_1_3_3_137_1 – ident: e_1_3_3_71_1 doi: 10.3390/ijms20030656 – ident: e_1_3_3_62_1 doi: 10.3390/molecules20010754 – ident: e_1_3_3_48_1 doi: 10.1016/j.ejmech.2017.07.024 – ident: e_1_3_3_131_1 – ident: e_1_3_3_106_1 – ident: e_1_3_3_52_1 doi: 10.1016/j.phymed.2004.07.006 – ident: e_1_3_3_45_1 doi: 10.3390/molecules24081617 – ident: e_1_3_3_76_1 doi: 10.2174/1872213X13666190621125048 – ident: e_1_3_3_122_1 – ident: e_1_3_3_27_1 doi: 10.1016/j.bbamem.2013.09.009 – ident: e_1_3_3_115_1 – ident: e_1_3_3_107_1 doi: 10.1016/j.phymed.2008.12.021 – ident: e_1_3_3_4_1 doi: 10.1021/acs.jafc.7b06010 – start-page: 7674 volume-title: Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (16th Edition). year: 2015 ident: e_1_3_3_21_1 contributor: fullname: Aronson JK – ident: e_1_3_3_32_1 doi: 10.3109/10715762.2010.515216 – volume: 5 start-page: 139 issue: 4 year: 2000 ident: e_1_3_3_61_1 article-title: Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative-topographical EEG in healthy volunteers publication-title: Eur. J. Med. Res. contributor: fullname: Vonderheid-Guth B – ident: e_1_3_3_8_1 doi: 10.3389/fvets.2017.00131 – ident: e_1_3_3_51_1 doi: 10.1021/np049783i – ident: e_1_3_3_58_1 doi: 10.3390/molecules23030660 – ident: e_1_3_3_13_1 doi: 10.1016/B978-0-12-373891-2.00052-3 – ident: e_1_3_3_70_1 doi: 10.3390/biom9110738 – ident: e_1_3_3_31_1 doi: 10.1021/tx020100d – ident: e_1_3_3_69_1 doi: 10.1016/j.phymed.2007.09.008 – ident: e_1_3_3_141_1 – ident: e_1_3_3_135_1 doi: 10.1007/978-3-030-11211-0_1 – start-page: 49 volume-title: Effects – Efficacy of Individual Hop Components. year: 2008 ident: e_1_3_3_49_1 contributor: fullname: Biendl M – ident: e_1_3_3_125_1 – ident: e_1_3_3_78_1 doi: 10.1016/j.lfs.2015.06.004 – ident: e_1_3_3_128_1 – ident: e_1_3_3_84_1 doi: 10.1007/s40291-018-0329-9 – ident: e_1_3_3_60_1 doi: 10.1556/APhysiol.99.2012.2.6 – ident: e_1_3_3_73_1 doi: 10.3389/fphar.2019.01336 – volume-title: For the Love of Hops: The Practical Guide to Aroma, Bitterness and the Culture of Hops. year: 2012 ident: e_1_3_3_7_1 contributor: fullname: Hieronymus S – ident: e_1_3_3_98_1 doi: 10.1016/j.phymed.2010.01.007 |
SSID | ssj0001127898 |
Score | 2.2413356 |
SecondaryResourceType | review_article |
Snippet | There is expanding proof that specific natural compounds found in plants have additional conventional medicinal properties. One such compound is xanthohumol... |
SourceID | proquest crossref pubmed futurescience |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 37 |
SubjectTerms | anti-inflammatory antidiabetic bone disorders flavonoids pharmaceutical |
Title | Recent patents on therapeutic activities of xanthohumol: a prenylated chalconoid from hops |
URI | http://dx.doi.org/10.4155/ppa-2020-0026 https://www.ncbi.nlm.nih.gov/pubmed/33445965 https://search.proquest.com/docview/2478589116 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9NAFB7q-iKIKN5WVxlBRCmpyeTuW1mURRYp0oW-hTPJZNu1m4Ruw9L9Rf5Mz5lJm7R2YfUlTUNnOs35OvPNl3Nh7D1RDqX80HICCCwPZGxJ21dWGkMAQkAucu3l-yM4OfO-T_xJr_e747VUL-UgvdkbV_I_VsVraFeKkv0Hy246xQt4jvbFI1oYj3eyMXI-epQ_Qr5YGN1_3IZT9YeprgwxM2llJ0BpAqb1ZTk3Ac6jhSpWcyDGeTwFei5VzjIksuUluc5oMZYk_npeX_VP68q8DtbKQcNnR9MtSbzSI-mDznSycagZnp_D4lpXFsAp9hp-wcYj-KyCbLqCVeMgNJ3NO7orrqpa9PkJF60biAnnJocDpapGuG1UC-F0VAs9uQncl1tRbBJID1T32s7sbP-FQjPVmlwxzaJt0p7uLgdElqiGcQUIG0ER9GJP2u2d5XDjpIjbI-ogweYJNU-o-T12X4Sx73d0Ia3mORRRrMsfrn-YSehKPXzeGsAWAXpoMsc0bOf2XY5mO-PH7FGzTeFDg7knrKeKp6wyeOMN3nhZ8A7eeIs3Xua8g7cvHHiLNt6ijRPaOKGNf-QN1niDNX46-PSMjb99HR-fWE3FDitFGry0II5lEGZOmNky8ImcR55wpO-4ys5dF89EinwWfFfKAHBzkbp2lHqRlwWxk7nuc3ZQlIV6yXgWhxn58tsiB09IEaU5lUIQEhdFaQfqkH1Y38WkMnlZkr0GO2Ri6x4n5t3ac-W2Ru_WhkhwuqVnaFCosr5KhBdGVIjTwc-8MBbafL_rep4fB_6ru47tNXvQ_jeO2MFyUas3yHGX8q2G1x91uqcg |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+Patents+on+Therapeutic+Activities+of+Xanthohumol%3A+a+Prenylated+Chalconoid+From+Hops+%28+Humulus+Lupulus+L.%29&rft.jtitle=Pharmaceutical+patent+analyst&rft.au=Aggarwal%2C+Diwakar&rft.au=Upadhyay%2C+Sushil+K&rft.au=Singh%2C+Raj&rft.au=Tuli%2C+Hardeep+S&rft.date=2021-01-01&rft.issn=2046-8954&rft.eissn=2046-8962&rft.volume=10&rft.issue=1&rft.spage=37&rft.epage=49&rft_id=info:doi/10.4155%2Fppa-2020-0026&rft.externalDBID=n%2Fa&rft.externalDocID=10_4155_ppa_2020_0026 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-8954&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-8954&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-8954&client=summon |